Selection of patients for aspirin desensitization treatment.
Stevenson
Donald D
DD
Division of Allergy, Asthma and Immunology, Scripps Clinic and the Scripps Research Institute, La Jolla, CA 92037, USA. Stevensn.donald@Scrippshealth.org
Simon
Ronald A
RA
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000276:immunology; D001241:Aspirin / Q000009:adverse effects* / Q000276:immunology; D001249:Asthma / Q000150:complications / Q000517:prevention & control; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity / Q000150:complications / Q000517:prevention & control*; D004802:Eosinophilia / Q000150:complications / Q000517:prevention & control; D006801:Humans; D009298:Nasal Polyps / Q000150:complications / Q000517:prevention & control; D018579:Patient Selection; D012852:Sinusitis / Q000150:complications / Q000517:prevention & control
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin